Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Propiophenone derivatives in the treatment of pathological muscular conditions

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Link salvestatakse lõikelauale
Eiichi Morita
Takeo Kanai

Märksõnad

Patendiinfo

Patendi number3995047
Esitatud03/10/1976
Patendi kuupäev11/29/1976

Abstraktne

New propiophenone derivatives prepared by the reaction of propiophenone, formaldehyde and piperidine, as well as pharmacologically acceptable acid-addition salts thereof are provided, which possess improved pharmacological activities such as anti-tremorine and anti-nicotine activities superior to those of the known analogous compound. The new compounds are useful for the therapeutic treatment of human patient suffering from pathological muscular contracture, spastic paralysis due to cerebral apoplexy, spinal and cerebral palsies and the like.

Nõuded

1. A method for the treatment of pathological muscular contracture, spastic paralysis due to cerebral apoplexy, and spinal and cerebral palysies, which comprises administering a therapeutically effective amount of a 4'-substituted 2-methyl-3-piperidino-propiophenone derivative represented by the formula: ##SPC4##

wherein R stands for a lower alkyl group having 2 to 3 carbon atoms or a pharmacologically acceptable acid-addition salt thereof to a human patient

2. A method according to claim 1 wherein the derivative is 4'-ethyl-2-methyl-3-piperidino-propiophenone or a pharmacologically

3. A method according to claim 1 wherein the derivative is 4'-n-propyl-2-methyl-3-piperidino-Propiophenone or a pharmacologically

4. A method according to claim 1 wherein the derivative is 4'-isopropyl-2-methyl-3-piperidino-propiophenone or a pharmacologically acceptable acid-addition salt thereof.

Kirjeldus

Following Examples will serve to illustrate the embodiments of the production of the compounds contemplated in the invention, but the invention, of course, is not intended to be limited thereby.

EXAMPLE 1

Preparation of 4'-ethyl-2-methyl-3-piperidino-propiophenone

To 60 mls. of isopropanol, there are introduced 120 grs. of 4-ethyl-propiophenone, 28.8 grs. of paraformaldehyde and 107 grs. of piperidine hydrochloride, and the resulting mixture is heated to reflux on an oil bath with stirring. The heating is continued, and when the reaction mixture solidifies, the state being a sign of completion of the reaction, there are added 500 mls. of acetone thereinto. The solidified mass is pulverized by crush, recovered by filtration and washed with acetone. 144 Grs. of the crude crystalline substance are thus obtained which are the hydrochloride of the purposed product. The hydrochloride is recrystallized from isopropanol, and there are obtained the crystalline needles having the melting point of 170.degree.-172.degree. C.

Elementary analysis of the product presumed as C.sub.17 H.sub.25 NO.HCl gives:

______________________________________ C H N ______________________________________ Calculated (%): 69.00 8.87 4.73 Found (%): 68.99 8.92 4.59 ______________________________________

EXAMPLE 2

Preparation of 4'-isopropyl-2-methyl-3-piperidino-propiophenone

To 350 mls. of isopropanol, there are introduced 350 grs. of 4-isopropyl-propiophenone, 270 grs. of a 30% aqeous formaldehyde and 266 grs. of piperidine hydrochloride together with 5 mls. of concentrated hydrochloric acid. The resulting mixture is heated to reflux on an oil bath with stirring for three hours. 500 mls. of acetone are then added to the reaction mixture with stirring. Crystals separate out from the reaction mixture are recovered by filtration and washed with acetone. There is thus obtained the crude hydrochloride of the purposed product in a crystalline form. The yield of the product amounts to 440 grs. The product is recrystallized from isopropanol and shows the melting point of 172.degree.-174.degree. C.

Elementary analysis of the product presumed as C.sub.18 H.sub.27 NO.HCl gives:

______________________________________ C H H ______________________________________ Calculated (%): 69.75 9.12 4.52 Found (%): 69.86 9.21 4.29 ______________________________________

EXAMPLE 3

A compound depicted in the following Table is prepared in accordance with the procedure disclosed in Example 1.

Table ______________________________________ Elementary Analysis Molecular Formula Calculated (%) R (Melting Point) (Found) (%) ______________________________________ C H N C.sub.18 H.sub.27 NO . HCl 69.75 9.12 4.52 --CH.sub.2 CH.sub.2 CH.sub.3 (168.degree. - 169.degree. C.) (69.40) (9.21) (4.43) ______________________________________

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge